MCP-1、vWF-cp及GK1与维持性血液透析患者血管钙化的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

四川省干部保健科研项目(川干研2021-231);四川省医学科研课题(S20014&S21002);成都市医学科研课题(2020208);金牛区医学会2021年科研课题(JNKY2021-85)


The relationship between monocyte chemoattractant protein factor-1, von Willebrand factor-cleaving protease and glucocorticoid-regulated protein kinase 1 and vascular calcification in MHD patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨单核细胞趋化蛋白因子-1(MCP-1)、血管性血友病因子裂解酶(vWF-cp)及糖皮质激素调节蛋白激酶1(GK1)与维持性血液透析(MHD)患者血管钙化的关系。方法 回顾性分析2019年1月—2021年1月四川省人民医院、金牛区人民医院、成都康福肾脏病医院、四川德森肾脏病医院收治的127例MHD患者的临床资料,将其设为观察组,根据有无出现血管钙化又将观察组分为钙化组(n=51)、未钙化组(n=76)。同时选取86例同时期体检健康者作为对照组。比较MCP-1、vWF-cp、GK1水平,分析影响MHD患者血管钙化的因素。结果 观察组MCP-1、GK1水平高于对照组,而vWF-cp水平低于对照组(P<0.05)。钙化组MCP-1、GK1水平高于未钙化组,而vWF-cp水平低于未钙化组(均P<0.05)。性别、高血压、糖尿病等非影响MHD患者血管钙化的单因素(P>0.05),年龄、透析龄、血钙、钙磷乘积、吸烟史、MCP-1、vWF-cp、GK1为影响MHD患者血管钙化的单因素(P<0.05)。经非条件多因素 logistic回归模型分析显示,年龄、透析龄、血钙、钙磷乘积、MCP-1、vWF-cp、GK1为影响MHD患者血管钙化的独立危险因素(P<0.05)。结论 MHD患者通常伴随有MCP-1、GK1水平升高,vWF-cp水平降低,且MCP-1、vWF-cp、GK1是其血管钙化的影响因素,临床可根据其水平变化进行针对性干预,预防血管钙化的发生

    Abstract:

    Objective To study the relationship between monocyte chemoattractant protein factor-1 (MCP-1), von Willebrand factor-cleaving protease (vWF-cp) and glucocorticoids glucocorticoid-regulated protein kinase 1 (GK1) and vascular calcification in maintenance hemodialysis (MHD) patients. Methods The clinical data of 127 MHD patients admitted to 4 hospitals from January 2019 to January 2021 were retrospectively analyzed, and they were set as the study group, and according to the presence or absence of vascular calcification, they were divided into the calcification group (n= 51), non-calcified group (n=76). At the same time, 86 healthy subjects with physical examination during the same period were selected as the control group. The levels of MCP-1, vWF-cp and GK1 were compared, and the factors affecting vascular calcification in MHD patients were analyzed. Results The levels of MCP-1 and GK1 in the study group were higher than those in the control group, while the level of vWF-cp was lower than that in the control group (P<0.05). The levels of MCP-1 and GK1 in the calcified group were higher than those in the non-calcified group, while the level of vWF-cp was lower than that in the non-calcified group (P<0.05). Gender, hypertension, diabetes and other factors were not the single factors affecting vascular calcification in MHD patients (P>0.05), while age, dialysis age, serum calcium, calcium-phosphorus product, smoking history, MCP-1, vWF-cp, and GK1 were the single factors affecting vascular calcification in MHD patients (P<0.05). Unconditional multivariate logistic regression model analysis showed that age, dialysis age, serum calcium, calcium-phosphorus product, MCP-1, vWF-cp, GK1 were independent risk factors for vascular calcification in MHD patients (P<0.05). Conclusion MHD patients are usually accompanied by increased levels of MCP-1 and GK1, and decreased levels of vWF-cp, and MCP-1, vWF-cp, and GK1 are the influencing factors of vascular calcification, and clinically, targeted intervention can be carried out according to its level changes to prevent the occurrence of vascular calcification

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-02-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司